跳至主要内容
临床试验/ACTRN12611000869976
ACTRN12611000869976尚未招募未知

The release of Phospholipase A2 biomarkers during percutaneous coronary intervention in patients with significant coronary artery disease and the relationship of released biomarkers with optical coherence tomography and intravascular ultrasound tissue characterisation.

Sir Charles Gairdner Hospital0 个研究点目标入组 50 人开始时间: 2011年8月16日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients undergoing elective percutaneous coronary intervention
  • age 18 to 85 years

排除标准

  • Myocardial Ischaemic event <14 days prior to participation
  • Change in HMG Co-A reductase inhibitor (statin) in the last 30 days
  • Current acute or chronic inflammatory condition
  • Coronary vessels unsuitable for invasive imaging, including planned left main stenting

研究者

相似试验